Go Back To Menu
Close
- Mailing Form
-
Medical Report*
-
Go Back To Menu
Cervical cancer is highly prevalent in developing countries, especially in East Africa and South Asia, with India, Pakistan, and Nigeria being particularly affected. In Europe and North America, screening systems are well established, resulting in lower incidence rates. However, incidence is rising in China and Thailand.
1. Persistent HPV Infection Leading to Lesions
Persistent infection with high-risk HPV can cause abnormal proliferation of cervical cells. Without intervention, this may develop into precancerous lesions or invasive cancer. The disease progresses slowly but carries high risks, requiring timely detection and management.
2. Local Tissue Destruction and Metastasis
In advanced cases, patients may develop cervical erosion, ulcers, bleeding, and invasion into the uterus, vagina, or pelvic lymph nodes. If cancer cells spread to the abdominal cavity or distant organs, treatment becomes much more difficult.
3. Physiological and Psychological Burden
Treatment often requires hysterectomy or pelvic lymph node dissection, impacting fertility and causing physiological changes. At the same time, patients face psychological pressures such as anxiety, unease, and depression, requiring multidisciplinary support.
4. Social and Family Burden
The long treatment course and aggressive interventions affect work, family roles, and quality of life, while also creating financial burdens. In resource-limited regions, this exacerbates disparities in healthcare resources.
By reinfusing activated immune cells, this therapy enhances the immune system’s ability to recognize and eliminate HPV infections and tumor cells. It improves the immune microenvironment, reduces recurrence risk, and is suitable as an adjuvant to surgery, radiotherapy, and chemotherapy, with potential to improve long-term survival and quality of life.
In clinical treatment, patients undergoing surgery, radiotherapy, or chemotherapy often face immune dysfunction, increased risk of infection, and slow recovery. To better support patients, improve tolerance, and enhance survival quality, immune reconstruction plans should be scientifically staged according to different treatment cycles.
● Short-term Plan: Quickly enhance immunity through immune cell reinfusion, boosting anti-tumor treatment effects.
● Mid-term Plan: Reduce side effects of conventional therapies, promote physical recovery, and complete standard regimens.
● Long-term Plan: Strengthen overall immunity through immune cell, intestinal, elemental, and nutritional reconstruction, improving quality of life and extending survival.
1. Surgery
Early cervical cancer is usually treated with conservative surgery such as cervical conization or hysterectomy. The surgical approach depends on the extent of lesions and patient fertility plans, helping to remove lesions and slow disease progression.
2. Radiotherapy
Used for middle-to-late-stage or high-risk postoperative patients, radiotherapy destroys cancer cells through external beam radiation or brachytherapy, controlling local lesions. Modern precision radiotherapy improves efficacy while reducing side effects.
3. Chemotherapy
Often combined with radiotherapy for advanced cervical cancer, chemotherapy suppresses cancer spread or shrinks tumors. It is especially important for metastatic or recurrent cases, though it carries risks such as bone marrow suppression.
4. Targeted and Endocrine Therapy
Some cervical cancer patients may benefit from targeted drugs based on molecular characteristics, such as EGFR or VEGF antibodies or small molecule drugs, though this is still in the exploratory and personalized stage.
5. Traditional Chinese Medicine (TCM) Adjuvant Therapy
TCM can regulate immunity, alleviate fatigue, and reduce side effects from radiotherapy and chemotherapy. When used in combination with Western medicine, it enhances overall efficacy and improves patient quality of life.
Cervical cancer causes multiple harms to women’s health, requiring strengthened screening and treatment. Experts from United Life International Medical Center emphasize that immune reconstruction cell therapy offers valuable support to comprehensive strategies, with promise in adjuvant treatment and recurrence reduction.
